APA

Slater M. J., Andrews D. M., Baker G., Bethell S. S., Carey S., Chaignot H., Clarke B., Coomber B., Ellis M., Good A., Gray N., Hardy G., Jones P., Mills G. & Robinson E. (20030520). Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease. : Bioorganic & medicinal chemistry letters.

Chicago

Slater Martin J, Andrews David M, Baker Graham, Bethell Susanne S, Carey Seb, Chaignot Helene, Clarke Berwyn, Coomber Barry, Ellis Malcolm, Good Andrew, Gray Norman, Hardy George, Jones Paul, Mills Gail and Robinson Ed. 20030520. Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease. : Bioorganic & medicinal chemistry letters.

Harvard

Slater M. J., Andrews D. M., Baker G., Bethell S. S., Carey S., Chaignot H., Clarke B., Coomber B., Ellis M., Good A., Gray N., Hardy G., Jones P., Mills G. and Robinson E. (20030520). Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease. : Bioorganic & medicinal chemistry letters.

MLA

Slater Martin J, Andrews David M, Baker Graham, Bethell Susanne S, Carey Seb, Chaignot Helene, Clarke Berwyn, Coomber Barry, Ellis Malcolm, Good Andrew, Gray Norman, Hardy George, Jones Paul, Mills Gail and Robinson Ed. Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease. : Bioorganic & medicinal chemistry letters. 20030520.